Drug intelligence / Profile preview

BMG0703

Development stage
Phase 3
Lead developer
BMG Pharma
Modality
Small Molecules
Administration
Oral
01

Overview

BMG0703 is a multi-ingredient, film-forming mouthwash developed by **BMG Pharma** for oral care and wound healing applications. The formulation combines **hydrogen peroxide**, **sodium hyaluronate** (hyaluronic acid), and **glycine**. It functions via a dual mechanism: hydrogen peroxide acts as an oxidative antimicrobial agent to reduce bacterial load and control plaque, while sodium hyaluronate forms a protective, hydrating physical barrier over the oral mucosa. This film facilitates tissue regeneration and protects surgical sites or periodontal pockets from external irritation. Glycine is included as a biochemical precursor to support collagen synthesis and accelerated wound repair. BMG0703 is primarily investigated for its efficacy in promoting healing after third molar extractions and in the management of periodontitis by reducing bleeding gums and periodontal pocket depth.

Other names
hydrogen peroxide + sodium hyaluronate + glycine mouthwash
02

Targets

HMMRCD44 (CD44 antigen)

Beyond the preview

Go deeper on BMG0703.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BMG0703.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call